Medulloblastoma: tumorigenesis, current clinical paradigm, and efforts to improve risk stratification

  title={Medulloblastoma: tumorigenesis, current clinical paradigm, and efforts to improve risk stratification},
  author={W. Polkinghorn and N. Tarbell},
  journal={Nature Clinical Practice Oncology},
  • W. Polkinghorn, N. Tarbell
  • Published 2007
  • Medicine
  • Nature Clinical Practice Oncology
  • Medulloblastoma is the most common brain malignancy in children and tremendous advances have recently been made in understanding the pathogenesis of this tumor. The Hedgehog and Wingless signaling pathways are implicated in medulloblastoma development, and both pathways were discovered as a result of analyses of genetic syndromes associated with the tumor. Over the past 80 years, considerable progress has been made in the treatment of what was once a fatal disease. The first survival reports… CONTINUE READING
    173 Citations
    Medulloblastoma: From Molecular Pathology to Therapy
    • 145
    • PDF
    Where are we with Targeted Therapies for Medulloblastoma
    Pediatric medulloblastoma in the molecular era: what are the surgical implications?
    Antiangiogenic Strategies in Medulloblastoma: Reality or Mystery
    • 23
    • PDF
    Molecular biology of medulloblastoma: bridging the gap between research and practice
    The rationale for targeted therapies in medulloblastoma.
    • 51
    • PDF


    Anaplasia and Grading in Medulloblastomas
    • 96
    Current treatment approaches to early childhood medulloblastoma
    • 32
    Clinical and molecular stratification of disease risk in medulloblastoma
    • 167
    • PDF
    Histopathologic grading of medulloblastomas
    • 250
    Staging, scoring and grading of medulloblastoma
    • 51
    The treatment and prognosis of medulloblastoma in children. A study of 82 verified cases.
    • 354